Study to Assess the Efficacy and Safety of AZD1981 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Moderate to Severe COPD
Interventions
DRUG

AZD1981

Oral tablet, twice daily

DRUG

Placebo

Placebo Oral tablet, twice daily

Trial Locations (21)

Unknown

Research Site, Pleven

Research Site, Rousse

Research Site, Sofia

Research Site, Varna

Research Site, Arhus C

Research Site, Hellerup

Research Site, Hvidovre

Research Site, Værløse

Research Site, Krakow

Research Site, Lublin

Research Site, Ostrów Wielkopolski

Research Site, Przemyśl

Research Site, Rzeszów

Research Site, Bojnice

Research Site, Liptovský Hrádok

Research Site, Poprad

Research Site, Spišská Nová Ves

Research Site, Žilina

Research Site, Lund

Research Site, Stockholm

Research Site, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY